Skye Bioscience

SKYENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$18.254 M

$0.52 +10.11%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$55.9M

Loss-making

Shares outstanding

33,378,764

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#403Citius PharmaceuticalsCTXR$18.7M
#404Marker TherapeuticsMRKR$18.7M
#405Skye BioscienceSKYE$18.3M
#406NewcelXNCEL$17.8M
#407LipocineLPCN$17.6M

Where these numbers come from

Share counts and financials for Skye Bioscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.